Adding heart rate signal to a control-to-range artificial pancreas system improves the protection against hypoglycemia during exercise in type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 16, Issue 8, 2014, Pages 506-511

  Breton, Marc D ^a   Brown, Sue A ^a   Karvetski, Colleen Hughes ^a   Kollar, Laura ^a   Topchyan, Katarina A ^a   Anderson, Stacey M ^a   Kovatchev, Boris P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ALGORITHM; ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DETERIORATION; DIABETIC PATIENT; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART RATE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LOW BG INDEX; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK REDUCTION; ADVERSE EFFECTS; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; FEASIBILITY STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PILOT STUDY; TREATMENT OUTCOME;

ADULT; ALGORITHMS; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; EXERCISE; FEASIBILITY STUDIES; FEMALE; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MONITORING, PHYSIOLOGIC; PANCREAS, ARTIFICIAL; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 84905253286     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0333     Document Type: Article

References (31)

1. Cryer PE: Hypoglycaemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 2002;45:937-948
2. Cryer PE: Mechanisms of hypoglycemia-Associated autonomic failure and its component syndromes in diabetes. Diabetes 2005;54:3592-3601
3. van Bon AC, Verbitskiy E, von Basum G, Hoekstra JBL, DeVries JH: Exercise in closed-loop control: a major hurdle. J Diabetes Sci Technol 2011;5:1337-1341
4. McMahon SK, Ferreira LD, Ratnam N, Davey RJ, Youngs LM, Davis EA, Fournier PA, Jones TW: Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner. J Clin Endocrinol Metab 2007;92:963-968
5. Goodyear LJ, Kahn BB: Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998;49:235-261
6. Dohm GL: Invited review: regulation of skeletal muscle GLUT-4 expression by exercise. J Appl Physiol 2002;93: 782-787
7. Younk LM, Mikeladze M, Tate D, Davis SN: Exerciserelated hypoglycemia in diabetes mellitus. Expert Rev Endocrinol Metab 2011;6:93-108
8. Toni S, Reali MF, Barni F, Lenzi L, Festini F: Managing insulin therapy during exercise in type 1 diabetes mellitus. Acta Biomed 2006;77(Suppl 1):34-40
9. Kumareswaran K, Elleri D, Allen JM, Caldwell K, Nodale M, Wilinska ME, Amiel SA, Hovorka R, Murphy HR: Accuracy of continuous glucose monitoring during exercise in type 1 diabetes pregnancy. Diabetes Technol Ther 2013;15:223-229
10. Riddell MC, Milliken J: Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study. Diabetes Technol Ther 2011;13:819-825
11. Cryer PE: The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-3176
12. Iscoe KE, Campbell JE, Jamnik V, Perkins BA, Riddell MC: Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technol Ther 2006;8:627-635
13. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B, International Artificial Pancreas Study Group: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237
14. Sherr JL, Cengiz E, Palerm CC, Clark B, Kurtz N, Roy A, Carria L, Cantwell M, Tamborlane WV, Weinzimer SA: Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care 2013;36:2909-2914
15. Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Farret A, Pelletier M, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle FJ III: Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancrea. Diabetes Care 2013;36:1851-1858
16. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:d1855
17. Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB: Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet 2010;375:743-751
18. Cobelli C, Renard E, Kovatchev BP, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle FJ 3rd, Patek SD, Avogaro A: Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care 2012;35: e65-e67
19. Renard EM, Farret A, Place J, Cobelli C, Kovatchev BP, Breton MD: Closed-loop insulin delivery using subcutaneous infusion and glucose sensing, and equipped with a dedicated safety supervision algorithm, improves safety of glucose control in type 1 diabetes [abstract]. Diabetologia 2010;53(Suppl 1):OP08
20. Cobelli C, Renard E, Kovatchev B: Artificial pancreas: past, present, future. Diabetes 2011;60:2672-2682
21. Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, Cheng P, Kollman C, Haidar A, Murphy HR, Wilinska M, Acerini CL, Dunger DB, Hovorka R: Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013;36:838-844
22. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER: A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2:27ra27
23. Breton MD: Physical activity-The major unaccounted impediment to closed loop control. J Diabetes Sci Technol 2008;2:169-174
24. Turksoy K, Bayrak ES, Quinn L, Littlejohn E, Cinar A: Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. Diabetes Technol Ther 2013;15:386-400
25. Turksoy K, Quinn L, Littlejohn E, Cinar A: Multivariable adaptive identification and control for artificial pancreas systems. IEEE Trans Biomed Eng 2014;61:883-891
26. Borg G, Noble BJ: Perceived exertion. In: Wilmore J, ed. Exercise and Sport Science Reviews. New York: Academic Press, 1974:131-154
27. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236:E667-E677
28. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W: Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care 1997;20:1655-1658
29. Kovatchev BP, Breton M, Man CD, Cobelli C: In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol 2009;3:44-55
30. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W: Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care 1998;21: 1870-1875
31. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Mahwah, NJ: Lawrence Erlbaum Associates, 1988.